Emergent BioSolutions获独家授权 将在FDA批准后向美国政府供应日本脑炎疫苗

美股速递
Apr 28

美国生物制药公司Emergent BioSolutions宣布,一旦其日本脑炎疫苗获得美国食品药品监督管理局批准,公司将正式成为该疫苗对美国政府的独家分销商。此项授权进一步巩固了Emergent BioSolutions在政府医疗对策供应领域的战略地位。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10